These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8885244)

  • 1. Effects of wild type and mutant estrogen receptors on DNA flexibility, DNA bending, and transcription activation.
    Potthoff SJ; Romine LE; Nardulli AM
    Mol Endocrinol; 1996 Sep; 10(9):1095-106. PubMed ID: 8885244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor-induced DNA bending: orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence.
    Nardulli AM; Grobner C; Cotter D
    Mol Endocrinol; 1995 Aug; 9(8):1064-76. PubMed ID: 7476980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
    Pakdel F; Reese JC; Katzenellenbogen BS
    Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation of DNA conformation by estrogen receptors alpha and beta.
    Schultz JR; Loven MA; Melvin VM; Edwards DP; Nardulli AM
    J Biol Chem; 2002 Mar; 277(10):8702-7. PubMed ID: 11773069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters.
    Nardulli AM; Romine LE; Carpo C; Greene GL; Rainish B
    Mol Endocrinol; 1996 Jun; 10(6):694-704. PubMed ID: 8776729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
    McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
    Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor mutants which do not bind 17 beta-estradiol dimerize and bind to the estrogen response element in vivo.
    Zhuang Y; Katzenellenbogen BS; Shapiro DJ
    Mol Endocrinol; 1995 Apr; 9(4):457-66. PubMed ID: 7659089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human estrogen receptor bound to an estrogen response element bends DNA.
    Nardulli AM; Greene GL; Shapiro DJ
    Mol Endocrinol; 1993 Mar; 7(3):331-40. PubMed ID: 8483477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor accessory proteins augment receptor-DNA interaction and DNA bending.
    Landel CC; Potthoff SJ; Nardulli AM; Kushner PJ; Greene GL
    J Steroid Biochem Mol Biol; 1997; 63(1-3):59-73. PubMed ID: 9449207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two transcription activation functions in the amino terminus of the mouse estrogen receptor that are affected by the carboxy terminus.
    Gandini O; Kohno H; Curtis S; Korach KS
    Steroids; 1997 Jul; 62(7):508-15. PubMed ID: 9253789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Powerful dominant negative mutants of the human estrogen receptor.
    Ince BA; Zhuang Y; Wrenn CK; Shapiro DJ; Katzenellenbogen BS
    J Biol Chem; 1993 Jul; 268(19):14026-32. PubMed ID: 8314770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms.
    Prendergast P; Pan Z; Edwards DP
    Mol Endocrinol; 1996 Apr; 10(4):393-407. PubMed ID: 8721984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA bending by nuclear receptors.
    Nardulli AM; Shapiro DJ
    Receptor; 1993; 3(4):247-55. PubMed ID: 8142903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional synergy between the transcription factor Sp1 and the estrogen receptor.
    Porter W; Saville B; Hoivik D; Safe S
    Mol Endocrinol; 1997 Oct; 11(11):1569-80. PubMed ID: 9328340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
    Elgort MG; Zou A; Marschke KB; Allegretto EA
    Mol Endocrinol; 1996 May; 10(5):477-87. PubMed ID: 8732679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter.
    Lazennec G; Kern L; Salbert G; Saligaut D; Valotaire Y
    Mol Endocrinol; 1996 Sep; 10(9):1116-26. PubMed ID: 8885246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.